SPI1 and lymphoma: Hence, myeloid-skewed TIS lymphomas provide stronger immunogenic signals, activate T-cells better, and present themselves as superior targets for T-cell-mediated senolysis as evidenced by reduced sensitivity of PU.1-depleted lymphomas and by higher susceptibility of the CD115+ TIS subpopulation.